Learn About Pineocytoma

What is the definition of Pineocytoma?
A Pineocytoma is a tumor of the pineal gland, a small organ in the brain that makes melatonin (a sleep-regulating hormone). Signs and symptoms of Pineocytomas include headaches, nausea, hydrocephalus, vision abnormalities, and Parinaud syndrome. Pineocytomas are usually slow-growing and rarely spread to other parts of the body.
What are the alternative names for Pineocytoma?
  • Pineocytoma
  • Pinealocytoma
  • Pinealoma
Who are the top Pineocytoma Local Doctors?
Katherine B. Peters
Advanced in Pineocytoma
Advanced in Pineocytoma

Duke Cancer Center

20 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Katherine Peters is a Neurologist in Durham, North Carolina. Dr. Peters is rated as an Advanced provider by MediFind in the treatment of Pineocytoma. Her top areas of expertise are Glioma, Gliomatosis Cerebri, Brain Tumor, and Astrocytoma. Dr. Peters is currently accepting new patients.

John P. Kirkpatrick
Advanced in Pineocytoma
Radiation Oncology
Advanced in Pineocytoma
Radiation Oncology

Duke Cancer Center Brain Tumor Clinic

20 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

John Kirkpatrick is a Radiation Oncologist in Durham, North Carolina. Dr. Kirkpatrick is rated as an Advanced provider by MediFind in the treatment of Pineocytoma. His top areas of expertise are Brain Tumor, Meningioma, Glioma, Astrocytoma, and Gamma Knife Radiosurgery. Dr. Kirkpatrick is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Pineocytoma
Radiation Oncology
Elite in Pineocytoma
Radiation Oncology

University Of California San Francisco

400 Parnassus Ave, Mcb300, 
San Francisco, CA 
Languages Spoken:
English
Offers Telehealth

David Raleigh is a Radiation Oncologist in San Francisco, California. Dr. Raleigh is rated as an Elite provider by MediFind in the treatment of Pineocytoma. His top areas of expertise are Meningioma, Pineocytoma, Brain Tumor, and Gliomatosis Cerebri.

What are the latest Pineocytoma Clinical Trials?
A First-in-human Phase I Single-agent Dose-escalation, Food Effect and Dose Expansion Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Summary: The primary objective of this Phase 1, open-label, dose-escalation, and exploratory study is to evaluate the safety and tolerability profile (establish the maximum-tolerated dose) and evaluate the occurrence of dose-limiting toxicities (DLTs) following single weekly or multiple-day weekly dose regimens of single-agent, oral ONC206 in patients with recurrent, primary central nervous system (CNS) ne...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Diagnosed According to cIMPACT-NOW Recommendations and the 2021 WHO Classification

Summary: Every new classification depends on its prognostic power and on the type of treatment given. With the rapid evolution of diagnostic methods and the advance in new treatments, there is much less reliable information available on how patients with newly defined brain tumour entities should be treated and what to expect from the current treatments. The goal is to determine whether the new 2021 WHO cl...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Pineocytoma?